Skip to main content

$6.600 (0%)

High

-

Low

-

Trades

-

Turnover

$0

Volume

0
20 June 2025 at 6:44pm
Register to track MDC and receive email alerts.
Subject
MDC Ann: Pause in Trading

MDC Ann: NanaBis Independently Confirmed BioAvailability

MDC Ann: Medlab signs exclusive commercial agreement with YesHealth

MDC Ann: Progression of NanoCelle NASAL COVID-19 Vaccine Program

MDC Ann: Biotech Investors Luncheon Presentations

MDC Ann: GTG: Biotech Investors Presentation

MDC Ann: Medlab Signs NRG Biotic Trade Deal with Cultech Ltd

MDC Ann: Quarterly Activities/Appendix 4C Cash Flow Report

MDC Ann: Quarterly Activities/Appendix 4C Cash Flow Report

MDC Ann: NanoCBD Awaiting UK Govt. Import Approval

MDC Ann: CEO Buys Medlab Shares - Appendix 3Y

MDC Ann: CEO Buys Medlab Shares - Appendix 3Y

MDC Ann: Half Yearly Report and Accounts

MDC Ann: UK Ethics favourable opinion for upcoming NanaBis P3 Trial

MDC Ann: Quarterly Activities/Appendix 4C Cash Flow Report

MDC Ann: Jobkeeper Notice

MDC Ann: Medlab Presenting at Jefferies London Healthcare Conference

MDC Ann: Further Information to Appendix 4C

MDC Ann: Medlab Completes Nutraceuticals Divestment to PharmaCare

MDC Ann: CEO Buys Medlab Shares - Appendix 3Y

MDC Ann: NanoCelle Patent Granted In USA

MDC Ann: Medlab Receives AusIndustry Overseas (R&D) Finding Approval

MDC Ann: Monthly Activities/Appendix 4C Cash Flow Report

MDC Ann: Appendix 3Y

MDC Ann: Notification regarding unquoted securities - MDC

MDC Ann: PharmaCare Purchases Medab's AUS Only Nutraceutical Business

MDC Ann: Results of Meeting

MDC Ann: Chairman's Address to Shareholders

MDC Ann: AGM Presentation

MDC Ann: Depression Patent for Orotate Approved by US Patent Office

MDC Ann: Nanocelle Issued Notice of Allowance by US Patent Office

MDC Ann: Proposed issue of securities - MDC

MDC Ann: Notice of Annual General Meeting/Proxy Form

MDC Ann: MDC Presentation - Update and Future Initiatives

MDC Ann: Appendix 4G

MDC Ann: Corporate Governance Statement

MDC Ann: Appendix 4E

MDC Ann: Annual Report to shareholders

MDC Ann: MDC Receives Approval for NanaBis PIII Trials from the TGA

MDC Ann: Quarterly Activities/Appendix 4C Cash Flow Report

MDC Ann: US Patent Office issues Notice of Allowance for NRGBiotic

MDC Ann: Medlab executes Master Services Agreement with WEP Clinical

MDC Ann: Australian Ethics Grants Approval for NanaBis PIII AUS Sites

MDC Ann: CommSec Correction to Medlab Directors Selling Shares

MDC Ann: Initial Director's Interest Notice

MDC Ann: Medlab NRGBiotic Depression Study Results

MDC Ann: Notification regarding unquoted securities - MDC

MDC Ann: Proposed issue of securities - MDC

MDC Ann: European and Canadian Patent Offices Grant NanoCelle Patents

MDC Ann: Medlab Presenting - LD Micro Invitational XI Conference 2021

Register to track MDC and receive email alerts.

Similar Companies

CSL ...
CSL
CUV
IMM
IMU
MSB
OPT
PAR
PYC
RAC
TLX